Beyer Anna T, Hui Peter Y, Hauesslein Ernest
Cardiology Department, California Pacific Medical Center, 2333 Buchanan Street, San Francisco, CA 94115, USA.
J Invasive Cardiol. 2010 Mar;22(3):E37-9.
Heart transplant recipients who experience humoral rejection are at risk for hemodynamic instability. We report a case of a 64-year-old male with cardiogenic shock due to allograft rejection requiring mechanical support while undergoing intense immunosuppression. He underwent implantation of a micro-axial endovascular pump (Impella). To our knowledge, this is the first reported case of successful Impella device deployment as a bridge-to-recovery strategy.
经历体液排斥反应的心脏移植受者存在血流动力学不稳定的风险。我们报告一例64岁男性患者，因同种异体移植排斥反应导致心源性休克，在接受强化免疫抑制治疗时需要机械支持。他接受了微型轴流血管内泵（Impella）植入术。据我们所知，这是首例成功将Impella装置作为过渡到康复策略进行部署的报道病例。
